Prestige Consumer Healthcare
PBH
#4454
Rank
A$3.55 B
Marketcap
A$74.98
Share price
0.06%
Change (1 day)
-17.32%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): A$4.76

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$4.93. In 2025 the company made an earnings per share (EPS) of A$5.76 a decrease over its 2024 EPS that were of A$6.50.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$4.76-17.38%
2025A$5.76-11.4%
2024A$6.50-367.08%
2023A-$2.43-138.33%
2022A$6.3511.7%
2021A$5.6813.6%
2020A$5.00-651.67%
2019A-$0.91-148.78%
2018A$1.86-83.29%
2017A$11.12437.23%
2016A$2.07-34.13%
2015A$3.1452.94%
2014A$2.05-8.11%
2013A$2.24
2011A$1.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.21 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.93 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.09-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$7.36 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$4.83-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.35-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$44.75-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.84-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel